Skip to main content
. 2002 Jun 1;109(11):1471–1479. doi: 10.1172/JCI14947

Figure 4.

Figure 4

The effect of endogenous IFN-γ on long-term cardiac allograft survival induced by CD154-CD40 blockade in a MHC-mismatched (BALB/c into C57BL/6) combination (a) or a minor-mismatched (129 into C57BL/6) combination (b). Wild-type or IFN-γ–/– recipients were treated with or without anti-CD154 mAb (administered at a dose of 500 μg intraperitoneally on day 0 and 250 μg on day 2, 4, and 6 after transplantation) as described in Methods. *P = 0.062; **P = 0.029.